                         SEQUENCE LISTING

<110>  Thomas Jefferson University
 
<120>  NEOANTIGEN COMPOSITIONS; AND METHODS OF PREPARATION AND USE 
       THEREOF

<130>  IMVX-013/01WO 327398-2059

<150>  US 62/736,861
<151>  2018-09-26

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  4099
<212>  DNA
<213>  Homo sapiens

<400>  1
atgaagtctg gctccggagg agggtccccg acctcgctgt gggggctcct gtttctctcc       60

gccgcgctct cgctctggcc gacgagtgga gaaatctgcg ggccaggcat cgacatccgc      120

aacgactatc agcagctgaa gcgcctggag aactgcacgg tgatcgaggg ctacctccac      180

atcctgctca tctccaaggc cgaggactac cgcagctacc gcttccccaa gctcacggtc      240

attaccgagt acttgctgct gttccgagtg gctggcctcg agagcctcgg agacctcttc      300

cccaacctca cggtcatccg cggctggaaa ctcttctaca actacgccct ggtcatcttc      360

gagatgacca atctcaagga tattgggctt tacaacctga ggaacattac tcggggggcc      420

atcaggattg agaaaaatgc tgacctctgt tacctctcca ctgtggactg gtccctgatc      480

ctggatgcgg tgtccaataa ctacattgtg gggaataagc ccccaaagga atgtggggac      540

ctgtgtccag ggaccatgga ggagaagccg atgtgtgaga agaccaccat caacaatgag      600

tacaactacc gctgctggac cacaaaccgc tgccagaaaa tgtgcccaag cacgtgtggg      660

aagcgggcgt gcaccgagaa caatgagtgc tgccaccccg agtgcctggg cagctgcagc      720

gcgcctgaca acgacacggc ctgtgtagct tgccgccact actactatgc cggtgtctgt      780

gtgcctgcct gcccgcccaa cacctacagg tttgagggct ggcgctgtgt ggaccgtgac      840

ttctgccaac atcctcagcg ccgagagcag cgactccgag gggtttgtga tccacgacgg      900

cgagtgcatg caggagtgcc cctcgggctt catccgcaac ggcagccaga gcatgtactg      960

catcccttgt gaaggtcctt gcccgaaggt ctgtgaggaa gaaaagaaaa caaagaccat     1020

tgattctgtt acttctgctc agatgctcca aggatgcacc atcttcaagg gcaatttgct     1080

cattaacatc cgacggggga ataacattgc ttcagagctg gagaacttca tggggctcat     1140

cgaggtggtg acgggctacg tgaagatccg ccattctcat gccttggtct ccttgtcctt     1200

cctaaaaaac cttcgcctca tcctaggaga ggagcagcta gaagggaatt actccttcta     1260

cgtcctcgac aaccagaact tgcagcaact gtgggactgg gaccaccgca acctgaccat     1320

caaagcaggg aaaatgtact ttgctttcaa tcccaaatta tgtgtttccg aaatttaccg     1380

catggaggaa gtgacgggga ctaaagggcg ccaaagcaaa ggggacataa acaccaggaa     1440

caacggggag agagcctcct gtgaaagtga cgtcctgcat ttcacctcca ccaccacgtc     1500

gaagaatcgc atcatcataa cctggcaccg gtaccggccc ctgactacag ggatctcatc     1560

agcttcaccg tttactacaa ggaagcaccc tttaagaatg tcacagagta tgatgggcag     1620

gatgcctgcg gctccaacag ctggaacatg gtggacgtgg acctcccgcc caacaaggac     1680

gtggagcccg gcatcttact acatgggctg aagccctgga ctcagtacgc cgtttacgtc     1740

aaggctgtga ccctcaccat ggtggagaac gaccatatcc gtggggccaa gagtgagatc     1800

ttgtacattc gcaccaatgc ttcagttcct tccattccct tggacgttct ttcagcatcg     1860

aactcctctt ctcagttaat cgtgaagtgg aaccctccct ctctgcccaa cggcaacctg     1920

agttactaca ttgtgcgctg gcagcggcag cctcaggacg gctaccttta ccggcacaat     1980

tactgctcca aagacaaaat ccccatcagg aagtatgccg acggcaccat cgacattgag     2040

gaggtcacag agaaccccaa gactgaggtg tgtggtgggg agaaagggcc ttgctgcgcc     2100

tgccccaaaa ctgaagccga gaagcaggcc gagaaggagg aggctgaata ccgcaaagtc     2160

tttgagaatt tcctgcacaa ctccatcttc gtgcccagac ctgaaaggaa gcggagagat     2220

gtcatgcaag tgcaacacca ccatgtccag ccgaagcagg aacaccacgg ccgcagacac     2280

ctacaacatc accgacccgg aagagctgga gacagagtac cctttctttg agagcagagt     2340

ggataacaag gagagaactg tcatttctaa ccttcggcct ttcacattgt accgcatcga     2400

tatccacagc tgcaaccacg aggctgagaa gctgggctgc agcgcctcca acttcgtctt     2460

tgcaaggact atgcccgcag aaggagcaga tgacattcct gggccagtga cctgggagcc     2520

aaggcctgaa aactccatct ttttaaagtg gccggaacct gagaatccca atggattgat     2580

tctaatgtat gaaataaaat acggatcaca agttgaggat cagcgagaat gtgtgtccag     2640

acaggaatac aggaagtatg gaggggccaa gctaaaccgg ctaaacccgg ggaactacac     2700

agcccggatt caggccacat ctctctctgg gaatgggtcg tggacagatc ctgtgttctt     2760

ctatgtccag gccaaaacag gatatgaaaa cttcatccat ctgatcatcg ctctgcccgt     2820

cgctgtcctg ttgatcgtgg gagggttggt gattatgctg tacgtcttcc atagaaagag     2880

aaataacagc aggctgggga atggagtgct gtatgcctct gtgaacccgg agtacttcag     2940

cgctgctgat gtgtacgttc ctgatgagtg ggaggtggct cgggagaaga tcaccatgag     3000

ccgggaactt gggcaggggt cgtttgggat ggtctatgaa ggagttgcca agggtgtggt     3060

gaaagatgaa cctgaaacca gagtggccat taaaacagtg aacgaggccg caagcatgcg     3120

tgagaggatt gagtttctca acgaagcttc tgtgatgaag gagttcaatt gtcaccatgt     3180

ggtgcgattg ctgggtgtgg tgtcccaagg ccagccaaca ctggtcatca tggaactgat     3240

gacacggggc gatctcaaaa gttatctccg gtctctgagg ccagaaatgg agaataatcc     3300

agtcctagca cctccaagcc tgagcaagat gattcagatg gccggagaga ttgcagacgg     3360

catggcatac ctcaacgcca ataagttcgt ccacagagac cttgctgccc ggaattgcat     3420

ggtagccgaa gatttcacag tcaaaatcgg agattttggt atgacgcgag atatctatga     3480

gacagactat taccggaaag gagggaaagg gctgctgccc gtgcgctgga tgtctcctga     3540

gtccctcaag gatggagtct tcaccactta ctcggacgtc tggtccttcg gggtcgtcct     3600

ctgggagatc gccacactgg ccgagcagcc ctaccagggc ttgtccaacg agcaagtcct     3660

tcgcttcgtc atggagggcg gccttctgga caagccagac aactgtcctg acatgctgtt     3720

tgaactgatg cgcatgtgct ggcagtataa ccccaagatg aggccttcct tcctggagat     3780

catcagcagc atcaaagagg agatggagcc tggcttccgg gaggtctcct tctactacag     3840

cgaggagaac aagctgcccg agccggagga gctggacctg gagccagaga acatggagag     3900

cgtccccctg gacccctcgg cctcctcgtc ctccctgcca ctgcccgaca gacactcagg     3960

acacaaggcc gagaacggcc ccggccctgg ggtgctggtc ctccgcgcca gcttcgacga     4020

gagacagcct tacgcccaca tgaacggggg ccgcaagaac gagcgggcct tgccgctgcc     4080

ccagtcttcg acctgctga                                                  4099


<210>  2
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  NOBEL phosphorothioate AS ODN


<220>
<221>  misc_feature
<222>  (1)..(18)
<223>  joined by a phosphorothioate linkage

<400>  2
tcctccggag ccagactt                                                     18


<210>  3
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  3
ttctccactc gtcggcc                                                      17


<210>  4
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  4
acaggccgtg tcgttgtc                                                     18


<210>  5
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  5
gcactcgccg tcgtggat                                                     18


<210>  6
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  6
cggatatggt cgttctcc                                                     18


<210>  7
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  7
tctcagcctc gtggttgc                                                     18


<210>  8
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  8
ttgcggcctc gttcactg                                                     18


<210>  9
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  9
aagcttcgtt gagaaact                                                     18


<210>  10
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  10
ggacttgctc gttggaca                                                     18


<210>  11
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  11
ggctgtctct cgtcgaag                                                     18


<210>  12
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  12
cagatttctc cactcgtcgg                                                   20


<210>  13
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  13
ccggagccag acttcat                                                      17


<210>  14
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  14
ctgctcctcc tctaggatga                                                   20


<210>  15
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Recombinant Insulin-like Growth Factor Receptor (IGF-1R) 
       antisense oligodeoxynucleotide (AS-ODN)

<400>  15
ccctcctccg gagcc                                                        15


